Published in Proc Soc Exp Biol Med on December 01, 1954
Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol (1999) 7.79
Association of a new type of cytopathogenic myxovirus with infantile croup. J Exp Med (1956) 5.24
Intestinal viral flora of healthy children demonstrable by monkey kidney tissue culture. Am J Public Health Nations Health (1956) 2.46
Evidence for frequent recombination within species human enterovirus B based on complete genomic sequences of all thirty-seven serotypes. J Virol (2004) 2.44
An unusual illness in young children associated with an enteric virus. Arch Dis Child (1956) 1.97
Vaccination against poliomyelitis with live virus vaccines. II. A trial of SM type I attenuated poliomyelitis virus vaccine. Br Med J (1957) 1.79
An endemiological study of enteric virus infections: poliomyelitis, coxsackie, and orphan (ECHO) viruses isolated from normal children in two socioeconomic groups. J Exp Med (1956) 1.75
ANIMAL AND PLANT VIRUSES WITH DOUBLE-HELICAL RNA. Proc Natl Acad Sci U S A (1963) 1.45
Junctional adhesion molecule a serves as a receptor for prototype and field-isolate strains of mammalian reovirus. J Virol (2005) 1.43
Structure and function of the reovirus genome. Microbiol Rev (1981) 1.33
Genetic marker studies of poliovirus. I. Natural variation. J Hyg (Lond) (1967) 1.30
Epidemiologic observations on an outbreak of aseptic meningitis due to ECHO virus type 6. Am J Public Health Nations Health (1957) 1.24
Factors determining pathogenicity of variants of ECHO 9 virus for newborn mice. J Exp Med (1959) 1.21
Viruses in sewage as an indicator of their presence in the community. J Hyg (Lond) (1981) 1.20
Problems associated with the use of live poliovirus vaccine. Am J Public Health Nations Health (1960) 1.19
Studies of a Coxsackie virus antigenically related to ECHO 9 virus and associated with an epidemic of aseptic meningitis with exanthem. Br J Exp Pathol (1958) 1.17
Factors influencing the occurrence of illness during naturally acquired polimyelitis virus infections. Bacteriol Rev (1960) 1.00
Detection of mammalian reovirus RNA by using reverse transcription-PCR: sequence diversity within the lambda3-encoding L1 gene. J Clin Microbiol (2002) 0.96
Observations on the Rous virus; fine structure and relation to cytoplasmic vacuoles. Br J Cancer (1957) 0.84
ENTEROVIRAL SYNDROMES IN TORONTO, 1964. Can Med Assoc J (1965) 0.82
Echovirus 7 associated with hand, foot, and mouth disease in mainland China has undergone a recombination event. Arch Virol (2015) 0.79
Mechanisms of reovirus bloodstream dissemination. Adv Virus Res (2013) 0.79
Aseptic meningitis caused by ECHO virus. J Hyg (Lond) (1957) 0.78
Applications of primary cell cultures in the study of animal viruses. III. Biological and genetic studies of enteric viruses of man (enteroviruses). Yale J Biol Med (1961) 0.77
Clinical, epidemiological, and virological aspects of echovirus type 9 infection in Sheffield, 1960. Br J Prev Soc Med (1962) 0.76
Aseptic meningitis, Montreal, 1969: a clinical and laboratory study. Can Med Assoc J (1971) 0.75
Naturally occurring reoviruses for human cancer therapy. BMB Rep (2015) 0.75
ECHO-11 as a respiratory virus: quantitation of infection in man. J Clin Invest (1968) 0.75
Living Poliomyelitis Vaccine. Can Med Assoc J (1957) 0.75
Investigation of acute gastroenteritis at a popular resort area. Public Health Rep (1961) 0.75
Research on dengue during World War II. Am J Trop Med Hyg (1952) 8.76
Evidence of continuous transmission of non-infectious SV 40 viral genome in most or all SV 40 hamster tumor cells. Proc Natl Acad Sci U S A (1963) 4.79
Reoviruses. A new group of respiratory and enteric viruses formerly classified as ECHO type 10 is described. Science (1959) 4.78
SOURCE OF GENETIC INFORMATION FOR SPECIFIC COMPLEMENT-FIXING ANTIGENS IN SV40 VIRUS-INDUCED TUMORS. Proc Natl Acad Sci U S A (1964) 4.78
Properties and behavior of orally administered attenuated poliovirus vaccine. J Am Med Assoc (1957) 4.50
Specificity of virus-induced resistance to transplantation of polyoma and SV 40 tumors in adult hamsters. Proc Soc Exp Biol Med (1963) 4.23
BEHAVIOR OF NONINFECTIOUS SV 40 VIRAL GENOME IN HAMSTER TUMOR CELLS: INDUCTION OF SYNTHESIS OF INFECTIOUS VIRUS. Proc Natl Acad Sci U S A (1963) 3.87
Present status of attenuated live-virus poliomyelitis vaccine. J Am Med Assoc (1956) 3.61
Present position of immunization against poliomyelitis with live virus vaccines. Br Med J (1959) 3.55
Live, orally given poliovirus vaccine. Effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses. JAMA (1960) 3.40
Enteropathogenic viruses and bacteria; role in summer diarrheal diseases of infancy and early childhood. J Am Med Assoc (1958) 3.17
Antibody response of patients with poliomyelitis to virus recovered from their own alimentary tract. J Exp Med (1949) 2.97
The dengue group of viruses and its family relationships. Bacteriol Rev (1950) 2.68
Present status of clinical manifestations of toxoplasmosis in man; indications and provisions for routine serologic diagnosis. J Am Med Assoc (1952) 2.62
Intestinal viral flora of healthy children demonstrable by monkey kidney tissue culture. Am J Public Health Nations Health (1956) 2.46
Pathogenesis of poliomyelitis; reappraisal in the light of new data. Science (1956) 2.37
ECHO type 9 virus disease. AMA J Dis Child (1958) 2.35
Studies on variants of poliomyelitis virus. I. Experimental segregation and properties of avirulent variants of three immunologic types. J Exp Med (1954) 2.33
Unique physico-chemical properties of Japanese B encephalitis virus hemagglutinin. Proc Soc Exp Biol Med (1950) 2.25
Community-wide use of oral poliovirus vaccine. Efectiveness of the Cincinnati program. Am J Dis Child (1961) 2.23
Properties of ECHO types 22, 23 and 24 viruses. Arch Gesamte Virusforsch (1961) 2.21
Genetic, hormonal and age factors in natural resistance to certain viruses. Ann N Y Acad Sci (1952) 2.13
DIARRHEAL DISEASES OF CHILDREN. THE OCCURRENCE OF ENTEROPATHOGENIC VIRUSES AND BACTERIA. Am J Dis Child (1964) 1.94
Transitory appearance of type 2 neutralizing antibody in patients infected with type 1 poliomyelitis virus. J Exp Med (1952) 1.94
Paralytic consequences of poliomyelitis infection in different parts of the world and in different population groups. Am J Public Health Nations Health (1951) 1.83
Characteristics and genetic potentialities of experimentally produced and naturally occurring variants of poliomyelitis virus. Ann N Y Acad Sci (1955) 1.76
Behavior of chimpanzee avirulent poliomyelitis viruses in experimentally infected human volunteers. Am J Med Sci (1955) 1.72
Development, persistence, and significance of type 2, poliomyelitis complement-fixing antibody in man. J Exp Med (1952) 1.68
Poliomyelitis virus of low virulence in patients with epidemic summer grippe or sore throat. Am J Hyg (1949) 1.62
SPECIFIC COMPLEMENT-FIXING TUMOR ANTIGENS IN HUMAN CELLS MORPHOLOGICALLY TRANSFORMED BY SV40 VIRUS. Proc Natl Acad Sci U S A (1964) 1.56
Immunization of chimpanzees and human beings with avirulent strains of poliomyelitis virus. Ann N Y Acad Sci (1955) 1.52
CAUSE AND CONTROL OF FATAL, INFANTILE DIARRHEAL DISEASES. Am J Trop Med Hyg (1963) 1.44
The hemagglutinin of St. Louis encephalitis virus. II. Physico-chemical properties and nature of its reaction with erythrocytes. J Immunol (1953) 1.43
Present status and future possibilities of a vaccine for the control of poliomyelitis. AMA Am J Dis Child (1953) 1.42
Skin reactions to toxoplasmic antigen in people of different ages without known history of infection. Pediatrics (1949) 1.38
The transmission of dengue by Aedes polynesiensis Marks. Am J Trop Med Hyg (1954) 1.38
The hemagglutinin of St. Louis encephalitis virus. I. Recovery of stable hemagglutinin from the brains of infected mice. J Immunol (1953) 1.38
Present status of attenuated live virus poliomyelitis vaccine. Bull N Y Acad Med (1957) 1.36
Antipoliomyelitic activity of human and bovine colostrum and milk. Pediatrics (1962) 1.33
Cytopathogenic enteric viruses associated with undifferentiated diarrheal syndromes in early childhood. Ann N Y Acad Sci (1957) 1.28
Recent advances in our knowledge of dengue and sandfly fever. Am J Trop Med Hyg (1955) 1.28
The hemagglutinin of St. Louis encephalitis virus. III. Properties of normal inhibitors and specific antibody; use of hemagglutination-inhibition for diagnosis of infection. J Immunol (1953) 1.26
[Present state of research on vaccination against poliomyelitis]. Brux Med (1954) 1.22
Factors determining pathogenicity of variants of ECHO 9 virus for newborn mice. J Exp Med (1959) 1.21
Effect of oral poliovirus vaccine in newborn children. II. Intestinal resistance and antibody response at 6 months in children fed type I vaccine at birth. Pediatrics (1963) 1.21
Picornaviruses: classification of nine new types. Science (1963) 1.17
Is there an exceedingly small risk associated with oral poliovirus vaccine? JAMA (1963) 1.17
Hemagglutination by viruses affecting the human nervous system. Fed Proc (1951) 1.15
Intratypic antigenic heterogeneity of Coxsackie B viruses. Arch Gesamte Virusforsch (1962) 1.15
Poliomyelitis viruses in tissue culture. VII. Experiences with viral and serological diagnostic procedures. Yale J Biol Med (1954) 1.14
Noncytopathogenic variants of poliomyelitis viruses and resistance to superinfection in tissue culture. Science (1954) 1.13
COMMENTARY ON REPORT ON ORAL POLIOMYELITIS VACCINES. JAMA (1964) 1.12
Immunization with live attenuated poliovirus vaccine. Am J Dis Child (1961) 1.10
Evaluation of Japanese B encephalitis vaccine. I. General background and methods. Am J Hyg (1956) 1.10
Properties and antigenic relationships of hemagglutinins associated with the dengue viruses. J Immunol (1954) 1.10
Nontuberculous diseases of the chest and related matters: miliary granulomatous pneumonitis in a group of men exposed to pigeon excreta. Trans Annu Meet Natl Tuberc Assoc (1951) 1.09
Toxoplasmosis; diagnosis and treatment. Trans Am Acad Ophthalmol Otolaryngol (1950) 1.09
The significance of viruses recovered from the intestinal tracts of healthy infants and children. Ann N Y Acad Sci (1956) 1.03
Japanese B encephalitis in American soldiers in Korea. Am J Hyg (1947) 1.03
Toxoplasmosis: current status and unsolved problems. Introductory remarks. Am J Trop Med Hyg (1953) 1.02
Immunity in poliomyelitis, with special reference to vaccination. Monogr Ser World Health Organ (1955) 1.01
Status of field trials with an orally administered, live attenuated poliovirus vaccine. J Am Med Assoc (1959) 1.00
Properties of epidemic strains of ECHO type 9 virus and observations on the nature of human infection. Arch Gesamte Virusforsch (1962) 0.99
EPIDEMIC DIARRHEA IN PREMATURE INFANTS. ETIOLOGICAL SIGNIFICANCE OF A NEWLY RECOGNIZED TYPE OF ESCHERICHIA COLI (0142:K86(B):H6). Am J Dis Child (1965) 0.98
Poliomyelitis in the tropics. Increasing incidence and prospects for control. Trop Geogr Med (1963) 0.97
Experimental studies on Phlebotomus (pappataci, sandfly) fever during World War II. Arch Gesamte Virusforsch (1951) 0.96
Topographic distribution of lesions in central nervous system in Japanese B encephalitis; nature of the lesions, with report of a case on Okinawa. Arch Neurol Psychiatry (1947) 0.95
Antipoliomyelitic substance in milk of human beings and certain cows. AMA Am J Dis Child (1950) 0.94
Studies of local antibody formation in the nervous system of paralyzed, poliomyelitis convalescent monkeys. J Immunol (1949) 0.93
Oral poliovirus vaccine. Recent results and recommendations for optimum use. R Soc Health J (1962) 0.92
Complement fixation test in toxoplasmosis and persistence of the antibody in human beings. Pediatrics (1949) 0.91
Persistence of placentally transmitted toxoplasmic antibodies in normal children in relation to diagnosis of congenital toxoplasmosis. Pediatrics (1949) 0.89
Genetic factors affecting susceptibility and resistance to virus diseases of the nervous system. Res Publ Assoc Res Nerv Ment Dis (1954) 0.88
The hemagglutinin of western equine encephalitis virus: recovery, properties and use for diagnosis. J Immunol (1954) 0.87
Poliomyelitis incidence in the Soviet Union in 1960. JAMA (1961) 0.85
Homotypic complement-fixing antibody in monkeys infected with type 2 poliomyelitis virus by the oral route. J Exp Med (1952) 0.85
A phase contrast microprecipitin test with poliovirus antigens. II. Occurrence and development of microprecipitin antibody after natural inapparent infections, after inoculation of Salk vaccine, after feeding of attenuated live poliovirus vaccine, and in disease caused by polioviruses and other enteroviruses. Arch Gesamte Virusforsch (1961) 0.85
Toxoplasmosis; diagnosis and treatment. Am J Ophthalmol (1950) 0.85
Effect of certain hormones and other chemical compounds on experimental poliomyelitis. AMA Am J Dis Child (1952) 0.84
Ultrafiltration and electron microscopy of three types of poliomyelitis virus propagated in tissue culture. Proc Soc Exp Biol Med (1954) 0.83
Epidemiology of athropodborne encephalitis. Neurology (1958) 0.82
Human toxoplasmosis; with special reference to intraocular inflammation; a critical review. Am J Ophthalmol (1956) 0.82
Clinically apparent and inapparent infection with Japanese B encephalitis virus in Shanghai and Tientsin. Proc Soc Exp Biol Med (1947) 0.82
Chorioretinopathy associated with other evidence of cerebral damage in childhood; a syndrome of unknown etiology separable from congenital toxoplasmosis. J Pediatr (1949) 0.82
Oral, live poliovirus vaccine for elimination of poliomyelitis. Arch Intern Med (1960) 0.81
Human infection with Rift Valley fever virus and immunity twelve years after single attack. Proc Soc Exp Biol Med (1947) 0.81
Transmission of poliomyelitis virus; analysis of differing interpretations and concepts, practical implications. J Pediatr (1951) 0.81
A complement fixation test for dengue. Proc Soc Exp Biol Med (1948) 0.81
Ecological studies on the mosquitoes of Okayama in relation to the epidemiology of Japanese B encephalitis. Am J Hyg (1950) 0.81
Insectborne virus diseases of military importance. Mil Med (1955) 0.79
Antigenic purity and plaque properties of the prototype strains of ECHO virus types 7 to 11, and 17 and 18. Arch Gesamte Virusforsch (1962) 0.79
Survey of knowledge and problems in field of arthropod-borne virus infections. Arch Gesamte Virusforsch (1959) 0.78
Problems in the natural history of poliomyelitis. Ann Intern Med (1949) 0.78
Relationships between arthropod-borne viruses based on antigenic analysis, growth requirements, and selective biochemical inactivation. Ann N Y Acad Sci (1953) 0.78
The hemagglutinin of West Nile virus: recovery, properties, and antigenic relationships. J Immunol (1954) 0.77
PROBLEMS IN THE DEVELOPMENT AND USE OF ORAL POLIOVIRUS VACCINE. Clin Pharmacol Ther (1964) 0.77
Levels of homotypic neutralizing antibody in human poliomyelitis three years after infection. J Exp Med (1952) 0.77